MacBeath Gavin bought TCRX
January 20, 2026 · Form 4 insider transaction
MacBeath Gavin bought 1,165,000 shares of TScan Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,165,000
Price
$0.00
Total value
N/A
InsiderMacBeath Gavin
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 20, 2026
Filing dateJanuary 22, 2026
Shares owned after1,165,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 20, 2026, with the balance vesting thereafter in equal monthly installments over the next 36 months, subject to the Reporting Person's continued service to the Issuer on each vesting date.